SPHK2 and cancer: Therefore, SPHK1 and SPHK2, as well as S1P itself, have been recognized as promising targets for cancer treatment, and many SPHK inhibitors, either selective or non-selective for SPHK1 and SPHK2, have been developed, some of which are now being used in clinical trials23,24.